Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HSK39004 Dry Powder Inhalation
NCT06971198 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2025-05-14
Summary
To evaluate the safety, tolerability and pharmacokinetic characteristics of HSK39004 dry powder inhalation in healthy subjects.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
HSK39004
0.75\~4mg
- DRUG
-
0.75\~4mg
Sponsors & Collaborators
-
Haisco Pharmaceutical Group Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-10
- Primary Completion
- 2025-03-28
- Completion
- 2025-05-06
Countries
- China
Study Locations
More Related Trials
-
Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers
NCT04213196 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers
NCT02746315 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers
NCT06926218 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants.
NCT06519968 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers
NCT05023525 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
NCT05656274 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of HS-10360 in Healthy Subjects.
NCT04986436 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers
NCT05663593 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)
NCT06821334 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
NCT06716151 ·Status: RECRUITING ·Phase: PHASE1
-
Phase 1a Study in Healthy Participants
NCT05953506 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
NCT06867393 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly Subjects
NCT04197661 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
NCT06999083 ·Status: RECRUITING ·Phase: PHASE1
-
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
NCT07241910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers
NCT03971916 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects
NCT05347758 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers
NCT05742126 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
NCT06612970 ·Status: RECRUITING ·Phase: PHASE1
-
The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
NCT03655873 ·Status: COMPLETED ·Phase: PHASE1
-
Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects
NCT05125211 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Trial of HRS-9813 in Healthy Volunteers
NCT06514963 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects
NCT04965337 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
NCT01476046 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of AK0610
NCT06996704 ·Status: RECRUITING ·Phase: PHASE1